PSG consensus statement on management of hepatitis C virus infection--2003

J Pak Med Assoc. 2004 Mar;54(3):146-50.
No abstract available

Publication types

  • Consensus Development Conference
  • Guideline
  • Practice Guideline
  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Carcinoma, Hepatocellular / etiology
  • Genotype
  • Hepacivirus / genetics*
  • Hepatitis C* / complications
  • Hepatitis C* / diagnosis
  • Hepatitis C* / drug therapy
  • Hepatitis C* / epidemiology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha* / therapeutic use*
  • Liver Neoplasms / etiology
  • Outcome Assessment, Health Care
  • Pakistan / epidemiology
  • Polyethylene Glycols*
  • Recombinant Proteins

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2b
  • peginterferon alfa-2a